Overbrook Management Corp Chembio Diagnostics, Inc. Transaction History

Overbrook Management Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $170,586 - $308,407	-52,008 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $165,385 - $808,204	52,008 New	52,008 $169,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

Stay updated on Overbrook Management Corp with notifications on news.